Neointimal regression-induced incomplete coverage of a bare-metal stent in the left main trunk: Serial angiographic and angioscopic evidence obtained by 5-year follow-up

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 6, 2009, Pages 787-790

  Ichikawa, Minoru ^a   Mishima, Masayoshi ^a  

^a KAWACHI GENERAL HOSPITAL   (Japan)

Author keywords

Angioscopy; Bare metal stent; Left main trunk; Very late stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANGIOSCOPY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CASE REPORT; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; REMISSION; STENT THROMBOSIS; TREATMENT RESPONSE; VASCULAR PATENCY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOSCOPY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RISK ASSESSMENT; STENTS; TIME FACTORS; TUNICA INTIMA;

EID: 65549114657     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21881     Document Type: Article

References (17)

1. Phisterer ME, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591.
2. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
3. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
4. Virmani R Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimuseluting stent: Should we be cautious? Circulation 2004;109: 701-705.
5. Feres F, Costa JR Jr, Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 2006;68:83-88.
6. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007;115:2435-2441.
7. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029.
8. Doyle B, Rihal CS, O'Sullivan CJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007;116: 2391-2398.
9. Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-1706.
10. Kotani J-I, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. J Am Coll Cardiol 2006;47:2108-2111.
11. Asakura M, Ueda Y, Nanto S, et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: Serial angiographic and angioscopic follow-up. Circulation 1998; 97:2003-2006.
12. Grewe PH, Deneke T, Machraoui A, Klaus-Michael Müller. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-163.
13. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;8:115:2426-2434.
14. Siqueira DA, Abizaid AA, Costa Jde R, et al. Late incomplete apposition after drug-eluting stent implantation: Incidence and potential for adverse clinical outcomes. Eur Heart J 2007;28: 1304-1309.
15. Celik T, Iyisoy A, Kursaklioglu H. A case of late stent thrombosis after exercise electrocardiography: Exercise- or residual plaque-induced? J Invasive Cardiol 2005;17:280-282.
16. Hayashi T, Kimura A, Ishikawa K. Acute myocardial infarction caused by thrombotic occlusion at a stent site two years after conventional stent implantation. Heart 2004;90:e26.
17. Chen JP. Very late drug-eluting stent thrombosis and cardiogenic shock: 1249 days after implantation. J Invasive Cardiol 2007;19:E381-E384.